Clinical Trial Update: Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial studying Vitamin D3 substitution in patients with primary immunodeficiency completed its Phase 1 and Phase 2 portions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Primary Immune Deficiency Disorder | Phase 1, Phase 2 | Status: COMPLETED